Inventor · disambiguated record
Jeffrey Greve
Also filed as: GREVE JEFFREY · GREVE JEFFREY M · GREVE JEFFREY MICHAEL
40 granted patents·22 pending applications·717 citations·filing 1989–2023
98Inventor score
Top patents by PatentIndex Score
62 records- 0198US10035836B1Modified IL-2 variants that selectively activate regulatory T cellsDELINIA INC·Filed 2015·Granted Jul 31, 2018·47 cites·5 claims
- 0297US10294287B2Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2017·Granted May 21, 2019·22 cites·13 claims
- 0395US10774126B2Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2019·Granted Sep 15, 2020·4 cites·9 claims
- 0494US6955807B1IL-2 selective agonists and antagonistsBAYER PHARMACEUTICALS CORP·Filed 1999·Granted Oct 18, 2005·140 cites·10 claims
- 0593US7105653B2IL-2 selective agonists and antagonistsSHANAFELT ARMEN B·Filed 2004·Granted Sep 12, 2006·85 cites·3 claims
- 0692US8835387B2Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseasesATYR PHARMA INC·Filed 2013·Granted Sep 16, 2014·18 cites·30 claims
- 0791US10766938B2Nucleic acid encoding human IL-2 variantDELINIA INC·Filed 2019·Granted Sep 8, 2020·2 cites·13 claims
- 0888US9273302B2Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseasesATYR PHARMA INC·Filed 2014·Granted Mar 1, 2016·10 cites·21 claims
- 0987US7785580B2Modified IL-4 mutein receptor antagonistsAEROVANCE INC·Filed 2007·Granted Aug 31, 2010·18 cites·17 claims
- 1085US10472405B2Multivalent regulatory T cell modulatorsDELINIA INC·Filed 2017·Granted Nov 12, 2019·3 cites·13 claims
- 1185US5235049ANucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1MOLECULAR THERAPEUTICS INC·Filed 1989·Granted Aug 10, 1993·53 cites·4 claims
- 1283US6028176AHigh-affinity interleukin-4 muteinsBAYER AG·Filed 1997·Granted Feb 22, 2000·40 cites·21 claims
- 1381US11446357B2Method for treating disease using FOXP3+CD4+ T cellsKYVERNA THERAPEUTICS INC·Filed 2021·Granted Sep 20, 2022·1 cites·15 claims
- 1481US10875901B2Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2019·Granted Dec 29, 2020·1 cites·13 claims
- 1580US11535657B2Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2019·Granted Dec 27, 2022·0 cites·11 claims
- 1679US2022112260A1Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2021·Application pending·0 cites
- 1778US11077172B2IL-2 variants for the treatment of psoriasisDELINIA INC·Filed 2017·Granted Aug 3, 2021·1 cites·13 claims
- 1877US11059877B2Multivalent regulatory T cell modulatorsDELINIA INC·Filed 2019·Granted Jul 13, 2021·1 cites·5 claims
- 1976US2021070828A1Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2020·Application pending·0 cites
- 2075US9822353B2PEGylated aspartyl-tRNA synthetase polypeptidesATYR PHARMA INC·Filed 2012·Granted Nov 21, 2017·2 cites·9 claims
- 2173US6313272B1DNA encoding high affinity interleukin-4 muteinsBAYER AG·Filed 1999·Granted Nov 6, 2001·20 cites·10 claims
- 2272US5821341AAntibodies to sICAM-1BAYER AG·Filed 1995·Granted Oct 13, 1998·16 cites·4 claims
- 2371US2021047382A1Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2020·Application pending·0 cites
- 2467US5589453AHuman rhinovirus receptor protein (ICAM-1) that inhibits rhinovirus attachment and infectivityMOLECULAR THERAPEUTICS INC·Filed 1994·Granted Dec 31, 1996·31 cites·6 claims
- 2567US2019375812A1Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2019·Application pending·0 cites
- 2666US6335426B1T-cell selective interleukin-4 agonistsBAYER AG·Filed 1999·Granted Jan 1, 2002·23 cites·4 claims
- 2766US6326004B1Antiviral methods using fragments of human rhinovirus receptor (ICAM-1)BAYER AG·Filed 1995·Granted Dec 4, 2001·13 cites·2 claims
- 2865US2021308222A1Il-2 variants for the treatment of autoimmune diseasesDELINIA INC·Filed 2021·Application pending·0 cites
- 2964US7404957B2Modified IL-4 mutein receptor antagonistsAEROVANCE INC·Filed 2004·Granted Jul 29, 2008·3 cites·30 claims
- 3064US2023104151A1A method for treating disease using foxp3+cd4+ t cellsKYVERNA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3163US5674982AMultimeric form of human rhinovirus receptor proteinBAYER AG·Filed 1995·Granted Oct 7, 1997·21 cites·3 claims
- 3263US2017327555A1Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2017·Application pending·0 cites
- 3362US6433157B1Polynucleotides encoding T-cell selective interleukin-4 agonistsBAYER AG·Filed 1999·Granted Aug 13, 2002·19 cites·25 claims
- 3462US5849699ASoluble molecule related to but distinct from ICAM-1BAYER AG·Filed 1995·Granted Dec 15, 1998·9 cites·3 claims
- 3561US2023330141A1Methods of producing t regulatory cells, methods of transducing t cells, and uses of the sameKYVERNA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3660US6514936B1Antiviral methods using human rhinovirus receptor (ICAM-1)BAYER AG·Filed 1994·Granted Feb 4, 2003·12 cites·4 claims
- 3760US2022169687A1Method for treating disease using foxp3+cd4+ t cellsKYVERNA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3860US2017204154A1Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2016·Application pending·0 cites
- 3960US2017051029A1Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2016·Application pending·0 cites
- 4060US2017037102A1Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2016·Application pending·0 cites
- 4159US9816084B2Aspartyl-tRNA synthetasesATYR PHARMA INC·Filed 2012·Granted Nov 14, 2017·0 cites·24 claims
- 4259US5986059AT-cell selective interleukin-4 agonistsBAYER AG·Filed 1997·Granted Nov 16, 1999·21 cites·11 claims
- 4358US5686582AMultimeric forms of human rhinovirus receptor proteinBAYER AG·Filed 1995·Granted Nov 11, 1997·12 cites·6 claims
- 4457US2024261405A1Methods and compositions for treating autoimmune diseaseKYVERNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4555US2022031751A1Methods of producing t regulatory cells, methods of transducing t cells, and uses of the sameKYVERNA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4655US2023399375A1Methods and compositions for treating autoimmune diseaseKYVERNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4753US6143298ASoluble truncated forms of ICAM-1BAYER AG·Filed 1995·Granted Nov 7, 2000·7 cites·12 claims
- 4853US6096862AMultimeric antiviral agentBAYER AG·Filed 1994·Granted Aug 1, 2000·9 cites·10 claims
- 4953US6051231AAntiviral methods and prepationsBAYER AG·Filed 1994·Granted Apr 18, 2000·11 cites·19 claims
- 5052US2003004314A1T-cell selective interleukin-4 agonistsFiled 2001·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jeffrey Greve files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →